HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Liver retransplantation in patients with acquired familial amyloid polyneuropathy: a Portuguese center experience.

Abstract
In 1995 Furtado et al performed the first domino transplantation using a donor liver with familial amyloid polyneuropathy (FAP), thereby increasing the pool of donors. Our experience showed that the onset of FAP symptoms occurs earlier in some patients. Patients with FAP acquired by transplantation are candidates for liver retransplantation to minimize the progression of symptoms. Liver retransplantation is considered to be a high-risk procedure and has lower survival compared with the first transplantation. We evaluated the risk of liver retransplantation in patients with acquired FAP. We did a retrospective analysis of these patients based on the records of perioperative data. From 1995 to 2004 we carried out 81 domino transplantations, of which 10 were submitted to liver retransplantation because of acquired FAP. The better outcomes in this group lead us to think that the liver retransplantation in patients with acquired FAP is not associated with the same risks of liver retransplantation in candidates with graft failure.
AuthorsH Vieira, C Rodrigues, L Pereira, J Jesus, C Bento, C Seco, F Pinto, A Eufrásio, S Calretas, N Silva, J Ferrão, L Tomé, A Barros, D Diogo, E Furtado
JournalTransplantation proceedings (Transplant Proc) Vol. 47 Issue 4 Pg. 1012-5 (May 2015) ISSN: 1873-2623 [Electronic] United States
PMID26036507 (Publication Type: Journal Article)
CopyrightCopyright © 2015 Elsevier Inc. All rights reserved.
Topics
  • Amyloid Neuropathies, Familial (mortality, surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Liver Transplantation (methods, mortality)
  • Male
  • Middle Aged
  • Portugal (epidemiology)
  • Reoperation
  • Retrospective Studies
  • Survival Rate (trends)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: